TY - T1的基线身体活动概要文件在CREST-2试验参与者(p1.3 - 056) JF -神经学乔-神经学六世- 92 - 15补充SP - p1.3 - 056 AU - Seemant首页查图尔维迪盟-谭雅图兰AU -尼尔·戈登AU -珍妮弗Voeks盟弗吉尼亚- Marc Chimowitz盟盟——乔治·霍华德AU -凯文·巴雷特盟盟罗伯特•布朗-罗纳德•拉扎尔盟Moy -韦斯利·摩尔盟克劳迪娅AU -加里Roubin盟-巴特Demaerschalk AU -马尔科姆·福斯特AU -劳伦斯韦氏盟Brajesh Lal AU -詹姆斯Meschia AU -托马斯王硕Y1 - 2019/04/09 UR - //www.ez-admanager.com/content/92/15_supplement/p1.3 056. -抽象N2 -目的:基于试验数据的颅内狭窄患者,我们旨在评估假设& lt; 40%的颈动脉狭窄的主题会有最佳的身体活动水平。我们也评估关键子组确定的物理活动模式。背景:身体活动的重要性在预防主要血管事件已经在过去的十年中受到更多的关注。由于包含INTERVENT生活方式的修改程序,CREST2试验提供了一个独特的机会来研究体育活动资料严重的无症状患者颅外颈动脉狭窄。设计/方法:我们分析了1087年CREST2参与者与基线数据在体力活动。Physician-based评估和咨询运动(速度)得分记录了每个病人和一分为二的“目标”(4 - 8分)或“目标”(& lt; 4点)。速度得分& lt; 4显示一个主题不参与有规律的锻炼。整个试验结果进行了分析。x平方分布检验和t进行小组评价的差异。结果:研究人口的平均年龄为69.5±7.8年(60%的男性)。基线的平均速度得分是4.0(平均3.8±2.1;差2—6)。表显示患者的基线特征意味着速度得分。 Being male, not having diabetes mellitus, having a body mass index <30kg/m2, being a non-smoker, and not having a history of peripheral arterial disease were associated with significantly higher mean PACE scores (P<0.01).Conclusions: We have defined several patient groups with asymptomatic carotid stenosis that have suboptimal physical activity. These results provide opportunities for targeted efforts to improve primary stroke prevention. These baseline data will also allow investigators to determine if trial involvement and the INTERVENT program leads to improvement in the level of physical activity.Disclosure: Dr. Chaturvedi has received personal compensation in an editorial capacity for NEJM Journal Watch Neurology. Dr. Chaturvedi has received research support from Boehringer Ingelheim. Dr. Turan has nothing to disclose. Dr. Gordon has nothing to disclose. Dr. Voeks has nothing to disclose. Dr. Chimowitz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bristol Myers Squibb. Dr. Howard has nothing to disclose. Dr. Howard has nothing to disclose. Dr. Barrett has nothing to disclose. Dr. Brown has nothing to disclose. Dr. Lazar has nothing to disclose. Dr. Moore has nothing to disclose. Dr. Moy has nothing to disclose. Dr. Roubin has nothing to disclose. Dr. Demaerschalk has nothing to disclose. Dr. Foster has nothing to disclose. Dr. Wechsler has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen and Athersys. Dr. Lal has nothing to disclose. Dr. Meschia has nothing to disclose. Dr. Brott has nothing to disclose. ER -